Admission Date:  [**2164-4-30**]              Discharge Date:   [**2164-5-16**]

Date of Birth:  [**2092-9-28**]             Sex:   F

Service: SURGERY

Allergies:
Penicillins / Sulfa (Sulfonamides)

Attending:[**First Name3 (LF) 4748**]
Chief Complaint:
ischemic left foot

Major Surgical or Invasive Procedure:
diagnositic arteriogram [**5-1**]
left SFA-AT bpg with insitu saphenous vein [**2164-5-7**]


History of Present Illness:
*-71y/o female initally evaluated ([**4-29**] ) at [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **]
Hospital for left foot ischemia
which became progressive over several days prior to admission
with foot pain with walking. No resat pain.workup included foot
film whic was negative for osteomylitis or fracture. She was
placed on leviquin for mild left heel erythemia. u/s of
extremity negative for DVT.there was an acute change in pulse
exam and foot color and temperature with increasing pain at
rest.Patien was began on heparin and transfered to [**Hospital1 8482**] under
the care of Dr. [**Last Name (STitle) 1391**] for further evaluaton and treatment on
[**2164-5-1**]

Past Medical History:
history of Dm2
history of chronic renal failure
history of atrial fibrillation
history of hypertension
history of coronary artery disease with ischemic cardiomyopathy
and systoic CHF
history of gout
history of DVt
history of chronic venous stasis ulcerations
history of osteoarthritis, degenerative s/p bilateral THR and
rt. TKR
history of depression
history of hypercholestremia


Social History:
married lives with spouse
former tobacco user
rare ETOH use

Family History:
unknown

Physical Exam:
VITAL SIGNS: 98.9-84-18 134/72 )2 sat 95%@2L/NC
GEN:oriented x3
HEENT: no LAD
HEART: RRR no mumur, gallop or rub
Lungs: clear to auscultation
ABD: obese, soft nontender
PV:paalpable femorals bilaterally, dopperable pedal pulses rt.
absetn pedal pulses left with cool, dusky foot which extends to
mid calf.

Neuro: nonfocal

Pertinent Results:
[**2164-4-30**] 05:59PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.016
[**2164-4-30**] 05:59PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-100
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0
LEUK-NEG
[**2164-4-30**] 05:59PM URINE  RBC-0-2 WBC-[**5-27**]* BACTERIA-FEW
YEAST-NONE EPI-0-2
[**2164-4-30**] 05:59PM URINE  HYALINE-0-2
[**2164-4-30**] 05:59PM URINE  AMORPH-MOD
[**2164-4-30**] 05:05PM   GLUCOSE-193* UREA N-34* CREAT-1.9* SODIUM-137
POTASSIUM-5.3* CHLORIDE-103 TOTAL CO2-26 ANION GAP-13
[**2164-4-30**] 05:05PM   estGFR-Using this
[**2164-4-30**] 05:05PM   CK(CPK)-74
[**2164-4-30**] 05:05PM   CALCIUM-9.1 PHOSPHATE-4.7* MAGNESIUM-2.2
[**2164-4-30**] 05:05PM   %HbA1c-6.8*
[**2164-4-30**] 05:05PM   WBC-9.7 RBC-4.74 HGB-13.7 HCT-42.0 MCV-89
MCH-29.0 MCHC-32.7 RDW-16.3*
[**2164-4-30**] 05:05PM   PLT COUNT-276
[**2164-4-30**] 05:05PM   PT-13.2* PTT-28.9 INR(PT)-1.2*

Brief Hospital Course:
[**5-1**] admitted.Diagnostic angio which demonstrated occluded SFA
and [**Doctor Last Name **]. Iv heparin continued. CK's monitered.
[**5-2**] admitting creatinine 1.9, post angio creatinine 3.1. Renal
consulted.B/P
parameters liberalized, IV hydration continued with NAHCO3 and
planned surgery
defered. C3C4 normal.IV heparin continued.
[**5-3**] slow improvement of renal function. placed on low K diet.
[**5-5**] continued improvment in renal function cr.2.4
[**2164-5-8**] DOS: left fme-disatal AT with insitu SVGbpg. Transfered
to PACU stable with dopperable left DP pulse. Transfered to ICU
for inotropic support.Dobutamine weaned overnight. Patient
transfered to VICU
[**5-9**] IV heparin discontinued..
[**2082-5-10**] Patient's PCA converted to oral analgesics. Swan
continued coumadin reinstuted for history of AF. Swan converted
to CVL.
ambulation began and PT consulted. JP drain discontinued.
[**2086-5-12**] agressive pulmonary care. Transfered to regular nursing
floor. required diamox for diursing. Lasix reinstuted. patient
encouraged to work with physical thearphy.CVL discontinued.
Foley discontinued.
[**5-16**] Patient screenedand accepted to rehab. Transfered to rehab
for less 30 day stay.

Medications on Admission:
meds added @ d/c to preadmit:
bisacodyl 10 mgm qd prn
dextromethorphan-guaifenesin 10/100mgm /5ml 5-10ml q6h prn
albuterol inhallation q6h prn
ipratropium bromide inhallation q6hprn
hydromorphone 2 mgm q3-4 hprn
percocet 5/325mgm q4-6h prn pain

Discharge Medications:
1. Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every
4 to 6 hours) as needed.
2. Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
3. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID
(2 times a day).
4. Bupropion 100 mg Tablet Sustained Release Sig: One (1) Tablet
Sustained Release PO QAM (once a day (in the morning)).
5. Digoxin 125 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).

6. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2)
Tablet, Delayed Release (E.C.) PO DAILY (Daily) as needed.
7. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2
times a day).
8. Trazodone 50 mg Tablet Sig: One (1) Tablet PO HS (at bedtime)
as needed.
9. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a
day).
10. Isosorbide Mononitrate 30 mg Tablet Sustained Release 24 hr
Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).
11. Warfarin 2 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).

12. Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO
Q4H (every 4 hours) as needed.
13. Dextromethorphan-Guaifenesin 10-100 mg/5 mL Liquid Sig: [**4-26**]
MLs PO Q6H (every 6 hours) as needed.
14. Albuterol Sulfate 0.083 % (0.83 mg/mL) Solution Sig: One (1)
 Inhalation Q6H (every 6 hours) as needed.
15. Ipratropium Bromide 0.02 % Solution Sig: One (1)  Inhalation
Q6H (every 6 hours) as needed.
16. Hydromorphone 2 mg Tablet Sig: One (1) Tablet PO Q3-4H
(Every 3 to 4 Hours) as needed.
17. Acetazolamide 250 mg Tablet Sig: 0.5 Tablet PO Q12H (every
12 hours).
18. Furosemide 40 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
19. Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical TID
(3 times a day) as needed.
20. Insulin NPH Human Recomb 100 unit/mL Suspension Sig: as
directed  Subcutaneous twice a day: NPH 50 units @ breakfast
NPH 40 units @ dinner.
21. Insulin Regular Human 100 unit/mL Solution Sig: as directed
Injection four times a day: AC:
glucoses <150 no insulin
glucoses 151-200/2u
glucoses 201-250/4u
glucoses 251-300/6u
glucoses 301-350/8u
glucoses 351-400/10u
glucoses >400 [**Name8 (MD) 138**] Md
HS:
glucoses < 250 no insulin
glucoses 251-300/2u
glucoses 301-350/4u
glucoses 351-400/6u
glucoses > 400 [**Name8 (MD) 138**] Md
u=units.


Discharge Disposition:
Extended Care

Facility:
[**Hospital3 2857**] - Maplewood - [**Location (un) 32944**]

Discharge Diagnosis:
ischemic left foot
history of DVT
history of atrial fibrillation
history of hypertension
history of coronary artery disease,ischemic
cardiomyopathy,systolic / diastolic dysfunction ,CHF
history of gout
history of osteoarthritis, degenerative ,s/p rt. TKR
history of chronic venous stasis ulcerations
history of morbid obesity
history of gall bladder disease s/p CCy
history of DM2, uncontrolled
history of depression
history of hypercholestremia
postangio contrast induced ATN, resolved
postop blood loss anemia, transfused
postoperative hypotension secondary to cardiomyopathy and
systollic/diastoic dysfucntion requiring inotrops, improved.


Discharge Condition:
stable


Discharge Instructions:
patient may shower no tub baths
ambulate essential distance ful weight bearing with ace wrap to
left foot to knee
elevate left foot and leg when sitting in chair
continue all medications as directed
continue a stool softner wqhile on pain medication
call if you develope a fever >101.5
call if you develop redness, drainage or groin sewlling at your
surgical wounds


Followup Instructions:
2 weeks. Dr. [**Last Name (STitle) 1391**] call for appointment [**Telephone/Fax (1) 1393**]



Completed by:[**2164-5-16**]